Use of anti-CS1 antibodies for treatment of rare lymphomas
摘要
Uses of anti-CS1 antibodies, alone or in combination with other agents, for the treatment of rare lymphomas, such as NK lymphomas, NK/T-cell lymphomas, and angioimmunoblastic lymphomas.
申请公布号
US8603477(B2)
申请公布日期
2013.12.10
申请号
US200913126754
申请日期
2009.10.29
申请人
AFAR DANIEL;HSI ERIC;ABBVIE BIOTHERAPEUTICS INC.;THE CLEVELAND CLINIC
